Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · IEX Real-Time Price · USD
0.428
+0.012 (2.89%)
At close: Jul 26, 2024, 3:55 PM
0.430
+0.002 (0.47%)
After-hours: Jul 26, 2024, 7:36 PM EDT

Ensysce Biosciences Revenue

Ensysce Biosciences had revenue of $305.72K in the quarter ending March 31, 2024, a decrease of -61.28%. This brings the company's revenue in the last twelve months to $1.75M, down -35.55% year-over-year. In the year 2023, Ensysce Biosciences had annual revenue of $2.23M, down -11.61%.

Revenue (ttm)
$1.75M
Revenue Growth
-35.55%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
7
Market Cap
3.25M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.23M-292.86K-11.61%
Dec 31, 20222.52M-1.01M-28.54%
Dec 31, 20213.53M-400.01K-10.18%
Dec 31, 20203.93M2.17M122.86%
Dec 31, 20191.76M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Xylo Technologies 91.72M
NovaBay Pharmaceuticals 14.23M
Petros Pharmaceuticals 4.69M
INVO Bioscience 4.25M
Fresh2 Group 2.35M
Akanda 2.16M
Revenue Rankings